Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
Operating Expenses | 45,961 | 36,461 | 33,046 | 22,187 | 135,012 |
Operating Income | -45,961 | -36,461 | -33,046 | -22,187 | -135,012 |
Interest Expense | 0 | 0 | 0 | 3,358 | 0 |
Other Income | 4,559 | 4,825 | 2,420 | -17,952 | 110 |
Pre-tax Income | -41,402 | -31,636 | -30,626 | -43,497 | -134,902 |
Income Tax | -159 | -50 | N/A | N/A | N/A |
Net Income Continuous | -41,243 | -31,586 | -30,509 | -43,497 | -134,902 |
Net Income | $-41,243 | $-31,586 | $-30,509 | $-43,497 | $-134,902 |
EPS Basic Total Ops | -0.41 | -0.32 | 47.32 | -10.71 | -43.82 |
EPS Basic Continuous Ops | -0.41 | -0.32 | 47.32 | -10.71 | -43.81 |
EPS Diluted Total Ops | -0.41 | -0.32 | 47.32 | -10.71 | -43.82 |
EPS Diluted Continuous Ops | -0.41 | -0.32 | 47.32 | -10.71 | -43.81 |
EBITDA(a) | $-45,874 | $-36,989 | $-33,660 | $-21,559 | $-135,012 |